Skip to main content
Premium Trial:

Request an Annual Quote

Protein Design Labs to Acquire Eos Biotechnology

NEW YORK, Feb. 5 - Protein Design Labs will acquire Eos Biotechnology in an all-stock transaction valued at $37.5 million, the Fremont, Calif., company said yesterday.

 

The merger is expected to close in the first quarter of 2003, subject to regulatory approval.

 

Protein Design Labs develops therapeutic antibodies for cancer treatment and immunologic disorders. Eos Biotechnology, of South San Francisco, uses its proprietary genomics platform to identify novel disease targets and develop antibodies.

 

Click here for more information.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.